Charles E. Rackley

9.0k total citations · 2 hit papers
187 papers, 6.4k citations indexed

About

Charles E. Rackley is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Charles E. Rackley has authored 187 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 130 papers in Cardiology and Cardiovascular Medicine, 70 papers in Radiology, Nuclear Medicine and Imaging and 67 papers in Surgery. Recurrent topics in Charles E. Rackley's work include Cardiac Imaging and Diagnostics (68 papers), Cardiovascular Function and Risk Factors (65 papers) and Hemodynamic Monitoring and Therapy (28 papers). Charles E. Rackley is often cited by papers focused on Cardiac Imaging and Diagnostics (68 papers), Cardiovascular Function and Risk Factors (65 papers) and Hemodynamic Monitoring and Therapy (28 papers). Charles E. Rackley collaborates with scholars based in United States, Australia and United Kingdom. Charles E. Rackley's co-authors include Richard O. Russell, William J. Rogers, John A. Mantle, Harold T. Dodge, J Pombo, William P. Hood, Huey G. McDaniel, Ellis L. Rolett, Roger E. Moraski and Curtis E. Green and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Circulation.

In The Last Decade

Charles E. Rackley

179 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measurement of Left Ventricular Wall Thickness and Mass by Echocardiography

1972 500 citations Charles E. Rackley et al. profile →
A Method for Determining Left Ventricular Mass in Man

1964 372 citations Charles E. Rackley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles E. Rackley United States	44	4.8k	2.2k	2.1k	653	606	187	6.4k
H.J.C. Swan United States	41	4.7k 1.0×	2.9k 1.4×	2.7k 1.3×	268 0.4×	894 1.5×	123	7.0k
Elliot Rapaport United States	36	3.8k 0.8×	1.2k 0.5×	1.8k 0.9×	390 0.6×	469 0.8×	114	5.8k
Edward L. Bolson United States	26	3.2k 0.7×	2.5k 1.2×	2.7k 1.3×	793 1.2×	487 0.8×	65	5.7k
Jacques R. Rouleau Canada	26	5.7k 1.2×	1.5k 0.7×	1.4k 0.7×	764 1.2×	432 0.7×	78	7.3k
Henry S. Loeb United States	36	7.0k 1.5×	945 0.4×	1.7k 0.8×	357 0.5×	645 1.1×	124	8.2k
Jacobus Lubsen Netherlands	35	4.6k 1.0×	1.2k 0.6×	1.5k 0.7×	339 0.5×	314 0.5×	108	6.2k
Hitoshi Hishida Japan	35	3.0k 0.6×	2.1k 1.0×	2.9k 1.4×	937 1.4×	627 1.0×	125	7.3k
C Conti United States	35	3.1k 0.7×	1.5k 0.7×	1.6k 0.8×	373 0.6×	269 0.4×	173	4.8k
Paul G. Hugenholtz Netherlands	38	3.5k 0.7×	2.0k 0.9×	2.1k 1.0×	134 0.2×	386 0.6×	105	5.0k
Peter F. Cohn United States	47	5.7k 1.2×	3.2k 1.5×	2.1k 1.0×	146 0.2×	373 0.6×	181	7.4k

Countries citing papers authored by Charles E. Rackley

Since Specialization

Citations

This map shows the geographic impact of Charles E. Rackley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Rackley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Rackley more than expected).

Fields of papers citing papers by Charles E. Rackley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles E. Rackley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Rackley. The network helps show where Charles E. Rackley may publish in the future.

Co-authorship network of co-authors of Charles E. Rackley

This figure shows the co-authorship network connecting the top 25 collaborators of Charles E. Rackley. A scholar is included among the top collaborators of Charles E. Rackley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles E. Rackley. Charles E. Rackley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Selker, Harry P., William S. Harris, Charles E. Rackley, et al.. (2016). Very early administration of glucose-insulin-potassium by emergency medical service for acute coronary syndromes: Biological mechanisms for benefit in the IMMEDIATE Trial. American Heart Journal. 178. 168–175. 6 indexed citations

Rackley, Charles E.. (2004). Hormones and Coronary Atherosclerosis in Women. Endocrine. 24(3). 245–250. 15 indexed citations

Rackley, Charles E.. (2004). New Clinical Markers Predictive of Cardiovascular Disease. Cardiology in Review. 12(3). 151–157. 12 indexed citations

Rackley, Charles E.. (2002). Strategies for the Prevention of Atherosclerotic Progression in Women. Cardiology in Review. 10(2). 119–125. 3 indexed citations

Rackley, Charles E.. (2001). Elderly Patients at Risk for Coronary Heart Disease or Stroke: Selecting an Ideal Product for Lipid Lowering. The American Journal of Geriatric Cardiology. 10(2). 77–84. 5 indexed citations

Bui, Minh, Michael T. Caulfield, Paul Katz, Richard O. Cannon, & Charles E. Rackley. (1996). Immune responses to HMG-CoA reductase inhibitors in patients with abnormal lipid level. Journal of the American College of Cardiology. 27(2). 413–413. 1 indexed citations

Rackley, Charles E.. (1996). Monotherapy with hMG‐CoA reductase inhibitors and secondary prevention in coronary artery disease. Clinical Cardiology. 19(9). 683–689. 24 indexed citations

Bui, Minh, et al.. (1996). Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. American Heart Journal. 131(4). 663–667. 66 indexed citations

Kuhn, Frederick E., Emile R. Mohler, & Charles E. Rackley. (1992). Cholesterol and lipoproteins: Beyond atherogenesis. Clinical Cardiology. 15(12). 883–890. 4 indexed citations

10.

Hong, Mun K., et al.. (1992). Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. The American Journal of Cardiology. 69(3). 176–178. 134 indexed citations

11.

Hong, Mun K., et al.. (1991). Total cholesterol/HDL ratio is the best predictor of anatomic coronary artery disease among elderly patients. Journal of the American College of Cardiology. 17(2). A151–A151. 1 indexed citations

12.

Green, Curtis E., et al.. (1991). Relation of serum lipoprotein cholesterol levels to presence and severity of angiographic coronary artery disease. The American Journal of Cardiology. 67(6). 479–483. 58 indexed citations

13.

Mohler, Emile R., et al.. (1991). Evidence for endothelial dysfunction and enhanced vasoconstriction in myocardial bridges. American Heart Journal. 122(6). 1764–1766. 40 indexed citations

14.

Kuhn, Frederick E., Emile R. Mohler, Lowell F. Satler, et al.. (1991). Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivity. The American Journal of Cardiology. 68(15). 1425–1430. 135 indexed citations

15.

Stark, Karen S., Lowell F. Satler, Mitchell W. Krucoff, Charles E. Rackley, & Kenneth M. Kent. (1990). Myocardial salvage after failed coronary angioplasty. Journal of the American College of Cardiology. 15(1). 78–82. 12 indexed citations

16.

Green, Curtis E., et al.. (1990). Relationship between lipid values and anatomic coronary artery disease in patients with total cholestrol below 200 mg/dl. Journal of the American College of Cardiology. 15(2). A155–A155. 1 indexed citations

17.

Satler, Lowell F., David L. Pearle, & Charles E. Rackley. (1989). Reduction in coronary heart disease: Clinical and anatomical considerations. Clinical Cardiology. 12(8). 422–426.

18.

Krucoff, Mitchell W., Antonio Parente, Randy K. Bottner, et al.. (1988). Stability of multilead ST-segment “fingerprints” over time after percutaneous transluminal coronary angioplasty and its usefulness in detecting reocclusion. The American Journal of Cardiology. 61(15). 1232–1237. 52 indexed citations

19.

Frye, Robert L., William W. Parmley, Nicholas J. Fortuin, et al.. (1986). Task force I: Training in clinical cardiology. Journal of the American College of Cardiology. 7(6). 1196–1200. 2 indexed citations

20.

Feild, Bolling J., et al.. (1973). Left ventricular function curves and ejection fraction in post-myocardial infarction patients. The American Journal of Cardiology. 31(1). 130–130. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact